In human-to-mouse xenograft models, reconstitution of human hematopoiesis is usually B-lymphoid dominant. ) mice showed significantly higher levels of human cell chimerism and long-term multi-lineage reconstitution compared with BRGS mice. Strikingly, this mouse displayed a robust reconstitution of human erythropoiesis and thrombopoiesis with terminal maturation in the bone marrow. Furthermore, depletion of host macrophages by clodronate administration resulted in the presence of human erythrocytes and platelets in the circulation. Thus, attenuation of mouse KIT signaling greatly enhances the multi-lineage differentiation of human hematopoietic stem and progenitor cells (HSPCs) in mouse bone marrow, presumably by outcompeting mouse HSPCs to occupy suitable microenvironments. The BRGSK Wv/Wv mouse model is a useful tool to study human multi-lineage hematopoiesis.
INTRODUCTION
Immunodeficient mice are widely used as hosts for xenogeneic transplantation to study human hematopoiesis in vivo (Doulatov et al., 2012; Goyama et al., 2015; Ishikawa, 2013; Rongvaux et al., 2013; Shultz et al., 2012) . Elimination of the mouse lymphoid system, including T, B, and natural killer (NK) cells, is necessary to prevent human graft rejection. Thus, mice with the scid mutation (Greiner et al., 1998; McCune et al., 1988; Shultz et al., 1995) or those lacking recombination activating gene 1 or 2 (Rag1 or Rag2) (Goldman et al., 1998; Shultz et al., 2000 Shultz et al., , 2003 have been used. In addition, these mice also had mutations in the interleukin-2 (IL-2) receptor common g-chain subunit (Il2rg) gene (Ishikawa et al., 2005; Ito et al., 2002; Shultz et al., 2005) . Previous studies reported that a non-obese diabetic (NOD) or BALB/c genetic background facilitates human hematopoietic stem cell (HSC) engraftment (Brehm et al., 2010) . Therefore, these strains with complete lymphoid depletion, such as NOD-scid Il2rg null (NSG/ NOG) (Ito et al., 2002; Shultz et al., 2005) , NOD.Rag1 null Il2rg null (NOD-RG) (Pearson et al., 2008) , and BALB/ c.Rag1/2 null Il2rg null (BALB-RG) (Brehm et al., 2010; Traggiai et al., 2004) mice, have been commonly used for recent xenotransplantation experiments. We found that the strain-specific genetic determinant of human HSC engraftment was a polymorphism in the signal-regulatory protein a (Sirpa) gene (Iwamoto et al., 2014; Takenaka et al., 2007; Yamauchi et al., 2013) . SIRPA is expressed on the surface of macrophages and binds to its ligand, CD47, which is ubiquitously expressed (Matozaki et al., 2009 ). This binding activates inhibitory signals for phagocytosis of CD47-expressing cells, termed the ''don't eat me signal'' Kuriyama et al., 2012; Majeti et al., 2009; Oldenborg et al., 2000) . In the setting of human-to-mouse xenotransplantation, this inhibitory signal is necessary to prevent engulfment of human graft cells by host macrophages. Although the binding of SIRPA and CD47 is species specific (Subramanian et al., 2006) , NOD and BALB/c mouse strains contain unique SIRPA immunoglobulin (Ig) domains that cross-react with human CD47 (Iwamoto et al., 2014; Takenaka et al., 2007) . With regard to human CD47, NOD-SIRPA has the strongest affinity while BALB/c-SIRPA has an intermediate affinity (Iwamoto et al., 2014) , and it is not recognized by C57BL/6-SIRPA. Based on these data, we developed a C57BL/6.Rag2 null Il2rg null mouse line harboring NOD-Sirpa (BRGS) (Yamauchi et al., 2013) . The efficiency of human cell engraftment in BRGS mice is significantly greater than in NOD-RG mice. Because BRGS mice do not possess a number of other NOD-specific abnormalities, including complement 5 deficiency (Yamauchi et al., 2013) , they are also useful for testing the complement-dependent cytotoxic activity of antibodies in vivo . Thus, the BRGS mouse line is one of the most efficient and convenient immunodeficient mouse strains for xenotransplantation.
However, in these models, human hematopoietic reconstitution is usually B-lymphoid dominant, and engraftment of human myeloid, erythroid, and megakaryocyte lineages is limited (Doulatov et al., 2012; Ito et al., 2012; Rongvaux et al., 2013; Yamauchi et al., 2013) . This skewed reconstitution could be due to the poor cross-reactivity of mouse cytokines with their corresponding human cytokine receptors (Manz, 2007) . Indeed, BALB-RG mice carrying the human thrombopoietin gene displayed enhanced human cell engraftment and myelomonocytic differentiation . The development of MITRG mice by further humanization of BALB-RG mice, generated by knocking in four human cytokines, namely macrophage colony-stimulating factor, granulocyte/macrophage colony-stimulating factor, IL-3, and thrombopoietin, has facilitated the functional development of human macrophages, monocytes, and NK cells (Rongvaux et al., 2014) . The receptor tyrosine kinase KIT, which is expressed on hematopoietic stem and progenitor cells (HSPCs), functions as an essential regulator of the interaction between these cells and their niches by binding to its ligand, stem cell factor (SCF) (Czechowicz et al., 2007; Lyman and Jacobsen, 1998) . Transgenic expression of membrane-bound human SCF in NSG mice resulted in improved human cell engraftment and myeloid differentiation (Takagi et al., 2012) . However, even in these models, only low levels of human erythroid and megakaryocyte reconstitution were present.
For successful full-lineage engraftment, human HSPCs may need to find suitable niches within the mouse bone marrow. It was shown that immunodeficient mice with loss-of-function Kit mutations (Waskow et al., 2009) or those treated with a neutralizing anti-mouse KIT antibody (Czechowicz et al., 2007) accepted donor mouse HSCs without irradiation preconditioning that may be critical for the depletion of host HSCs to open their niches. Recent studies also showed that irradiation preconditioning was not required for human HSPCs to engraft in BALB-RG or NSG mice with Kit W41 or Kit Wv mutations (Cosgun et al., 2014; McIntosh et al., 2015) . These studies suggest that impaired KIT signaling renders mouse HSCs uncompetitive in occupying putative niches, therefore allowing human HSCs to access to mouse HSC niches and to expand in the mouse bone marrow.
In the present study, we established a BRGS strain with loss-of-function Kit Wv mutation (BRGSK). The homozy- (Yamauchi et al., 2013) .
Because mice homozygous for Kit Wv are sterile (Nocka et al., 1990; Sharma et al., 2007) , the BRGSK Wv/Wv mouse was obtained by mating BRGSK Wv/+ pairs. BRGSK Wv/Wv mice had a white coat color ( Figure 1A) and developed severe macrocytic anemia with a significant decrease in erythrocyte count ( Figure 1B ), as seen in homozygous C57BL/6J-Kit Wv mice (Nocka et al., 1990; Sharma et al., 2007) . Figure 1C ). However, serial analysis of BRGSK mice revealed that aging did not exacerbate macrocytic anemia (data not shown). Their bone marrow cellularity and the number of HSCs and megakaryocyte-erythrocyte progenitors (MEPs) were similar to those in BRGS mice; in addition, they did not decline with age ( Figure 1D (Figure 2A, left panel) . We previously showed that human cell chimerism in male NOD-RG and BRGS recipients was lower than that in female recipients (Yamauchi et al., 2013) . However, under the same transplantation protocol, both male and female BRGSK Wv/Wv mice showed a similar excellent reconstitution ( Figure S2 ). It was also reported that human cell chimerism in the non-injected side was very low (McDermott et al., 2010; McKenzie et al., 2005; Yahata et al., 2003 Figure 2B , left panel). These data clearly show that the introduction of the Kit Wv allele into the BRGS strain has a significant impact on the level of human cell reconstitution, and that it also accelerates the homing of human HSCs to bone marrow niches via the circulation. We then analyzed the long-term repopulating activity of human HSCs at 20-24 weeks after transplantation, because it was reported that constant reconstitution (greater than 20 weeks) in xenogeneic hosts reflects the successful selfrenewal of human HSCs in mouse bone marrow (Notta et al., 2011 recipients and transplanted them into irradiated adult BRGS mice, multi-lineage engraftment of human hematopoietic cells was observed in 7 of 15 secondary recipients at 8 weeks after the secondary transplantation ( Figure 2C ). Collectively, the introduction of homozygous Kit Wv mutations into the BRGS strain is critical for the long-term maintenance and self-renewal of human HSCs. Figure S4 ). The gradual decline in human B cells and the increase in myeloid and NK cell frequencies in BRGSK recipient bone marrow after engraftment were compatible with our previous data in BRGS mice (Yamauchi et al., 2013 were also evident. Figure 4B shows the morphology of each myeloid subset purified from BRGSK Wv/Wv recipients.
We then tested the expression profiles of genes related to myeloid cell function or development. We used the Molecular Signatures Database v5.1 (http://www.broadinstitute. org/gsea/msigdb/index.jsp) to identify genes closely related to each myeloid subset. TPSB2 and CPA3 were chosen as representative genes for mast cells, RNASE2 and CLC for eosinophils, MPO and CXCR2 for neutrophils, LYZ, MAFB, and SLC7A7 for monocytes, CD1C and HLA-DR for cDCs, IRF7 and TNFRSF21 for pDCs, and FLT3 for both cDCs and pDCs. As shown in Figure 4C , each myeloid subpopulation expressed genes representative of their cellular properties, suggesting that they developed normally in the BRGSK Wv/Wv mouse model. There were no significant differences in the composition of myeloid cells among BRGS and BRGSK strains ( Figure 4D) . and 49.1% of human platelets, respectively, at 20-24 weeks after transplantation ( Figure 5B , right panel). Human erythroid and platelet reconstitution was also present in the non-injected left femur of BRGSK Wv/Wv mice, although the level of chimerism was low ( Figure S3 ). Representative FACS plots of the analysis of human erythroid development are shown in Figure 5A . CD71 (transferrin receptor) expression on human erythroid lineage cells gradually decreases as cells become mature (Giarratana et al., 2005; Miharada et al., 2006 
CD71
À CD235a + mature erythrocytes were clearly detectable, although the number of this population was low. The morphology of each purified fraction is shown in Figure 5C : CD71 + CD235a À cells were proerythroblasts and basophilic erythroblasts, CD71 + CD235a + cells were polychromatic to orthochromatic erythroblasts, and CD71 À CD235a + cells were enucleated mature erythrocytes. To visualize the broad distribution of human erythroid cells in BRGSK Wv/Wv recipient bone marrow, we performed three-dimensional (3D) confocal immunofluorescence imaging experiments by using whole-mount tissues of the mouse sternum (Kunisaki et al., 2013) stained with human CD71 and mouse TER119. Human hematopoiesis was efficiently reconstituted, even in the sternal bone marrow ( Figure 6C ). Interestingly, human and mouse erythropoiesis appeared to form ''erythroblastic islands'' ( Figure 6D Figure 6E ). These results suggest that human erythroid reconstitution is achieved by outcompeting host erythropoiesis for putative ''erythroid'' niches in the bone marrow of BRGSK Wv/Wv mice.
Systemic Depletion of Macrophages Releases Human Erythrocytes and Platelets into the Circulation of BRGSK Wv/Wv Mice
In previous human-to-mouse xenogeneic transplantation models, circulating human erythrocytes or platelets were not usually observed ( 2013; Takagi et al., 2012) . They were also undetectable in BRGSK Wv/Wv mice ( Figure 7A ). We considered that mature human blood cells might still be engulfed by mouse macrophages, even after the introduction of NOD-Sirpa, because hemosiderin was deposited in the spleen of BRGSK Wv/Wv mice with human hematopoietic reconstitution (data not shown). Previous studies reported that after xenotransplantation of a high dose (1-5 3 10 5 cells) of human CD34 + fetal liver cells, which have strong erythroid expansion potential (Holyoake et al., 1999) , the elimination of host macrophages by clodronate administration accelerated the peripheral distribution of human mature cells (Hu and Yang, 2012; Hu et al., 2011 
DISCUSSION
Although many immunodeficient mouse strains have been developed, it has become clear that most models display B-lymphoid dominant reconstitution after the xenogeneic transplantation of human HSPCs (Doulatov et al., 2012; Ito et al., 2012; Rongvaux et al., 2013; Yamauchi et al., 2013) . Genetically delivered human cytokines have greatly improved myelomonocytic differentiation Rongvaux et al., 2011 Rongvaux et al., , 2014 Takagi et al., 2012; Willinger et al., 2011) ; however, human erythroid and megakaryocyte reconstitution is still limited (Chen et al., 2009; Rongvaux et al., 2011; Takagi et al., 2012 (Nocka et al., 1990) . In addition, these phenotypes correspond to the degree of impairment in hematopoiesis (Sharma et al., 2007) . Based on these data, we chose to introduce the Kit Wv mutation into the BRGS strain, as it should provide the strongest inhibition of KIT signaling while still preserving the viable phenotype. Previous studies reported that the introduction of Kit
W41
or Kit Wv mutations into BALB-RG or NSG mice could render mouse HSCs uncompetitive to donor human HSCs (Cosgun et al., 2014; McIntosh et al., 2015) . They also showed that human HSPCs injected at a high dose (5 3 10 4 to 3 3 10 5 CD34 + CB cells), without irradiation preconditioning, could outcompete mouse HSCs for engraftment and differentiate into myeloerythroid cells. This is probably because the introduction of loss-of-function Kit mutations might render host HSCs uncompetitive in occupying HSC niches. The BRGSK Wv/Wv mouse also reconstituted human hematopoiesis, without irradiation, after a high dose of human HSPC transplantation (data not shown). However, when these mice were irradiated, A B Figure 7 . Effect of Systemic Macrophage Depletion on the Peripheral Distribution of Human Erythrocytes and Platelets in BRGSK Wv/Wv Mice BRGSK Wv/Wv recipients at 13 weeks after transplantation were injected intraperitoneally with clodronate (n = 3) or control (n = 3) liposomes for 3 weeks (200 ml for the first injection and 100 ml every 4 days thereafter). Human erythroid and megakaryocyte reconstitution were analyzed at 16 weeks after transplantation. Mice with Kit mutations display macrocytic anemia (Nocka et al., 1990 ) and impairment of megakaryopoiesis and myelopoiesis (Chervenick and Boggs, 1969; Ebbe et al., 1973) as the major hematopoietic phenotypes. These changes might be explained by the decreased affinity between HSPCs and their niches by attenuated KIT signaling. In this context, Kit mutations might help open the putative ''myeloid,'' ''erythroid,'' or ''megakaryocyte'' niches, resulting in the ample reconstitution of human myeloid, erythroid, and megakaryocyte cell lineages in the bone marrow. Indeed, robust human erythropoiesis occurred in the sternal bone marrow of BRGSK Wv/Wv mice, where human erythroid cells colonized, forming ''islands'' independently of mouse erythroid cells. This suggested that these cells migrated and competed for mouse ''erythroid'' niches in the bone marrow. However, the level of human CD235a (Ehninger and Trumpp, 2011) . New strategies to completely inhibit mouse macrophage activity against human cells should be developed to establish a more faithful humanized model with circulating mature human blood cells.
In BRGSK Wv/Wv mice, the level of myeloid reconstitution was up to 30% and 60% at 8-12 weeks and 20-24 weeks after transplantation, respectively. These levels might be comparable with those in MITRG mice in which four critical myeloid cytokines were humanized (Rongvaux et al., 2014) , although a direct comparison is difficult owing to differences in dose, source, and injection methods of human HSPCs. Specifically, MITRG mice were reconstituted with 10 5 human CD34 + fetal liver cells by intrahepatic injection. The humanization of key cytokines should be important for the functional maturation of myeloid cells Rongvaux et al., 2011 Rongvaux et al., , 2014 Willinger et al., 2011 
EXPERIMENTAL PROCEDURES
Mice C57BL/6J-Kit Wv mice were purchased from the Jackson Laboratory.
BRGS mice were developed in our laboratory (Yamauchi et al., 2013) . The BRGSK Wv/+ mouse was generated by breeding BRGS and heterozygous C57BL/6J-Kit Wv mice, and the BRGSK Wv/Wv mouse line was maintained by crossing BRGSK Wv/+ pairs. All mice were bred and maintained under specific pathogen-free conditions at the Kyushu University Animal Facility. Rag2, Il2rg, Sirpa, and Kit genes were genotyped by direct sequencing after PCR amplification to identify the genotype of BRGSK mice. Primer sequences are described in our previous report (Yamauchi et al., 2013) and the JAX website (http://jaxmice.jax.org/strain/000049.html).
Determination of the Irradiation Dose
To determine the irradiation dose for BRGSK mice, we first evaluated the effect of the Kit Wv allele on radiation sensitivities.
Groups of 6-to 10-week-old heterozygous or homozygous C57BL/6J-Kit Wv mice were irradiated by a 77.7-TBq (2.1 kCi) 137 Cs g-irradiator with a dose rate of 70 cGy/min and monitored for 8 weeks. As shown in Figure S1 , most C57BL/6J-Kit Wv heterozygotes receiving greater than 550 cGy irradiation died (Figure S1A) , and all C57BL/6J-Kit Wv homozygotes irradiated with greater than 200 cGy died within 3 weeks ( Figure S1B 
Immunohistochemistry and Whole-Mount Confocal Immunofluorescence Imaging
Sections prepared from paraformaldehyde-fixed paraffin-embedded mouse femoral bone marrow tissues were immunostained with antibodies. Sternal bones were harvested for immunofluorescence imaging and transected with a surgical blade into two fragments as described previously (Kunisaki et al., 2013) . The fragments were sagittally bisected to expose the bone marrow cavity and then fixed in 4% paraformaldehyde. Whole-mount tissues of the sterna were blocked and permeabilized in PBS containing 20% normal goat serum and 0.5% Triton X-100, then stained with antibodies for 2-3 days. Images were acquired using an Axio Examiner D1 microscope (Zeiss) with a confocal scanner unit, CSUW1CU (Yokogawa), and reconstructed in 3D using Image-Pro software (Media Cybernetics). Details about the antibodies used are provided in Supplemental Experimental Procedures.
Clodronate Treatment
Macrophages were depleted in vivo by intraperitoneal injection of clodronate-encapsulated liposomes (Clophosome-A; FormuMax Scientific). Clodronate liposomes were given at 200 mL per mouse for the first injection and then 100 mL per mouse every 4 days for 3 weeks. Control mice were treated at the same time with empty liposomes (Control anionic liposomes; FormuMax Scientific).
Gene-Expression Analysis
Reconstituted human CD235a + erythroid cells and each myeloid subpopulation within the CD33 + population were purified from BRGSK Wv/Wv mouse bone marrow, and examined for gene expression. Each target population was sorted directly to TRIzol (Life Technologies), and the total RNA extracted was reverse transcribed using the SuperScript III First-Strand Synthesis System (Invitrogen). Pre-amplification was performed using TaqMan PreAmp Master Mix (Applied Biosystems). cDNA samples were subjected to real-time qPCR using the Biomark system (Fluidigm). Expression of the GAPDH gene was used for normalization. Primers and probes used in this assay were obtained from Applied Biosystems.
Statistical Analysis
Student's t test was used for single comparisons, and one-way ANOVA followed by Tukey's HSD (honestly significant difference) test for multiple comparisons. All statistical analyses were performed using JMP software (version 11.0; SAS Institute, www.sas. com) and p values of less than 0.05 were considered statistically significant. The Mantel-Cox log-rank test was used to obtain survival curves. 
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